BIO’s McMurry-Heath steps down as head of biotech lobby
Bio Pharma Dive
OCTOBER 11, 2022
Her exit from the role follows reported disagreements over the group’s direction. Former GlycoMimetics CEO Rachel King will serve as interim CEO during the search for a successor.
Let's personalize your content